Dexcom has obtained 510(k) clearance from the FDA for its G6 Pro Continuous Glucose Monitoring System, which gathers real-time glucose data for 10 days in a blinded and unblinded mode. The device is indicated for patients ages two years and older.
Dexcom's continuous glucose monitoring system cleared by FDA
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.